Free Trial
OTCMKTS:VACBF

Nykode Therapeutics AS (VACBF) Stock Price, News & Analysis

$0.27 0.00 (0.00%)
As of 04/25/2025

About Nykode Therapeutics AS Stock (OTCMKTS:VACBF)

Key Stats

Today's Range
$0.27
$0.27
50-Day Range
$0.22
$0.27
52-Week Range
$0.22
$0.95
Volume
N/A
Average Volume
2,980 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

Receive VACBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nykode Therapeutics AS and its competitors with MarketBeat's FREE daily newsletter.

VACBF Stock News Headlines

Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
Nykode Therapeutics And 2 More Penny Stocks Worth Watching
Nykode Therapeutics AS (5VB.DU)
See More Headlines

VACBF Stock Analysis - Frequently Asked Questions

Nykode Therapeutics AS's stock was trading at $0.2408 on January 1st, 2025. Since then, VACBF stock has increased by 14.2% and is now trading at $0.2749.
View the best growth stocks for 2025 here
.

Shares of VACBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:VACBF
CIK
N/A
Fax
N/A
Employees
171
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:VACBF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners